News
-
5 April 2017
Immunocore Publishes Gender Pay Report -
28 February 2017
Immunocore to Present at the Cowen and Company 37th Annual Healthcare Conference -
1 December 2016
Immunocore wins Financing Deal of the Year at the 12th Annual SCRIP Awards 2016 -
9 November 2016
Immunocore Presents Positive Monotherapy Data in Uveal Melanoma at the Society for Melanoma Research (SMR) 2016 Congress -
12 October 2016
Immunocore Appoints Paul Fry as Chief Financial Officer -
12 September 2016
Immunocore Ranked in the Sunday Times Hiscox Tech Track 100 -
7 September 2016
Immunocore Wins Private UK Life Science Company of the Year at Biotech and Money Assembly and Awards. -
8 June 2016
Immunocore’s ImmTAV shown to redirect the immune system to kill HIV-infected cells from patients treated with antiretroviral therapy -
6 June 2016
Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting -
30 March 2016
Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma